Lonza Launches Media Development Lab in Singapore to Enhance Bioprocessing Efficiency

March 27, 2026 Lonza has announced the opening of a new Media Development Lab at its Singapore facility, aimed at improving cell culture media optimisation and supporting biopharmaceutical companies in streamlining their development processes. The initiative is designed to help customers create robust and scalable media formulations while ensuring a seamless transition to Good Manufacturing Practice (GMP) production.

The launch comes at a time when the biopharmaceutical industry is experiencing increasing pressure to accelerate development timelines while managing growing process complexity. Inefficient media optimisation and lack of alignment between early-stage development and large-scale manufacturing often lead to costly delays and higher risks during later stages of production.

A key feature of the Media Development Lab is its use of advanced methodologies such as Design of Experiments (DoE). This technique enables researchers to evaluate multiple variables simultaneously, allowing for a deeper understanding of how different factors influence cell culture performance. As a result, companies can identify critical process parameters more efficiently and accelerate development timelines while minimizing unnecessary experimental iterations. The lab also provides access to Lonza’s extensive and proprietary libraries of media and feed formulations. Combined with the company’s expertise in manufacturing, this resource helps customers identify high-performing, scalable solutions early in the development cycle. The output includes clearly defined performance ranges and insights into process robustness, supporting informed decision-making and smoother scale-up.

The establishment of the Media Development Lab further strengthens Lonza’s capabilities in supporting advanced biologics and specialized modalities. By bridging the gap between development and manufacturing, the company aims to enhance supply readiness and improve overall process reliability. This development highlights the growing importance of integrated solutions in the contract manufacturing and research services market, where efficiency, scalability, and speed are critical to meeting the rising demand for innovative biopharmaceutical products.

We focus exclusively on this industry and provide insights that help you make better decisions. Get in touch to learn more@ https://www.precedenceresearch.com/pharmaceutical-contract-manufacturing-and-research-services-market